Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies - Summary of Consolidated Balance Sheets (Details)

v3.26.1
Summary of Significant Accounting Policies - Summary of Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Condensed Balance Sheet Statements, Captions [Line Items]        
Other accrued expenses $ 22,266   $ 16,361  
Total current liabilities 72,292   151,593  
Total liabilities 98,064   205,262  
Additional paid-in capital 605,700   536,725  
Accumulated deficit (487,340)   (538,645)  
Total stockholders' equity 112,928   (11,687) $ 37,784
Total liabilities and stockholders' equity $ 210,992   193,575  
As Previously Reported        
Condensed Balance Sheet Statements, Captions [Line Items]        
Other accrued expenses   $ 21,985    
Total current liabilities   161,730    
Total liabilities   203,291    
Additional paid-in capital   576,758 536,184  
Accumulated deficit   (558,761) (538,104)  
Total stockholders' equity   5,555 (11,687)  
Total liabilities and stockholders' equity   208,846 193,575  
Restatement Adjustments        
Condensed Balance Sheet Statements, Captions [Line Items]        
Other accrued expenses   1,840    
Total current liabilities   1,840    
Total liabilities   1,840    
Additional paid-in capital   1,559 541  
Accumulated deficit   (3,399) (541)  
Total stockholders' equity   (1,840) 0  
Total liabilities and stockholders' equity   0 0  
Revised        
Condensed Balance Sheet Statements, Captions [Line Items]        
Other accrued expenses   23,825    
Total current liabilities   163,570    
Total liabilities   205,131    
Additional paid-in capital   578,317 536,725  
Accumulated deficit   (562,160) (538,645)  
Total stockholders' equity   3,715 (11,687)  
Total liabilities and stockholders' equity   $ 208,846 $ 193,575